Apart from finding a complete cure for HIV/AIDS, another important aspect of tackling the epidemic is looking for an effective way to stop its transmission. Scientists may have made a great discovery in that area.
A study, funded by the National Institute for Health, carried out in Europe for almost a decade was recently published on the Lancet medical journal. It aimed to confirm earlier observations that HIV transmissions are prevented between an HIV-positive individual with suppressed viral load through ART and an HIV-negative partner.
Researchers from the University College London gathered almost 1,000 gay couples from across Europe to participate in the study that ran from September 2010 through July 2017. During this period, the participants reportedly engaged in condomless intercourse, but the scientists have recorded zero transmissions. They have recorded 15 new infections, but it was found that the virus was not contracted from HIV-positive individuals not enrolled in the research.
“Our results provide a similar level of evidence on viral suppression and HIV transmission risk for gay men to that previously generated for heterosexual couples and suggest that the risk of HIV transmission in gay couples through condomless sex when HIV viral load is suppressed is effectively zero,” the study reads. “Our findings support the message of the U=U (undetectable equals untransmittable) campaign and the benefits of early testing and treatment for HIV.”
The study is of great importance while the world still searches for the ultimate HIV/AIDS cure. It proves that early HIV detection with proper ART medication that successfully suppresses the virus helps in stopping the further spread of the virus.
Meanwhile, this is not the only published study in 2019 that gives a huge hope in ending the HIV epidemic. In March, it was reported that a second HIV patient was “functionally cured” after receiving stem cell transplants for their Hodgkin’s lymphoma. The virus has since been undetectable in the patient's system despite stopping his ART medications for 18 months at the time of the report.


Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Lab-grown meat: you may find it icky, but it could drive forward medical research
Ancient Mars may have had a carbon cycle − a new study suggests the red planet may have once been warmer, wetter and more favorable for life
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 



